Concepedia

Author

Anna Norhammar

Karolinska InstitutetORCID

Also Known As

A NORHAMMAR, A Norhammar, A. Norhammar, A.N. Norhammar, ANNA NORHAMMAR, Anna Norhammar, Arya, Niki, John P. Wilding, Jonas Oldgren, K. Malmberg

238

Publications

14.8K

Citations

50

H-Index

36

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalSaint Göran HospitalUppsala UniversityStatisticon (Sweden)
AN

About

Anna Norhammar is an author at Karolinska Institutet specializing in cardiovascular disease, medicine, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

2.4K

2

Diabetes

9

9

2.2K

3

Public Health

6

7

1K

4

Social Sciences

1

1

28

5

Dental Hygiene

1

1

28

Anna Norhammar

×

77

Publications

8K

Citations

41

H-Index

YearCitations

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

Anna Norhammar, Åke Tenerz, Göran Nilsson,

The Lancet

2002

1.1K

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

Klas Malmberg, Anna Norhammar, Hans Wedel,

Circulation

1999

852

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu,

Circulation

2017

791

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Kåre I. Birkeland, Marit E. Jørgensen, Bendix Carstensen,

The Lancet Diabetes & Endocrinology

2017

363

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

Anna Norhammar, Klas Malmberg, Erik Diderholm,

Journal of the American College of Cardiology

2004

329

Periodontitis Increases the Risk of a First Myocardial Infarction

Lars Rydén, Kåre Buhlin, E Ekstrand,

Circulation

2016

309

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction

M. Bartnik, K. Malmberg, Anna Norhammar,

European Heart Journal

2004

282

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

Anna Norhammar, Johan Lindbäck, Lars Rydén,

Heart

2007

219

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes ( <scp>CVD‐REAL Nordic</scp> ) when compared with dipeptidyl peptidase‐4 inhibitor therapy: <scp>A</scp> multinational observational study

Frederik Persson, Thomas Nyström, Marit E. Jørgensen,

Diabetes Obesity and Metabolism

2017

214

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

Kåre I. Birkeland, Johan Bodegård, Jan W. Eriksson,

Diabetes Obesity and Metabolism

2020

211

Page 1